bluebird bioBLUE
BLUE
$0.5289
6.8%
Market Cap: $102M
0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
5% less funds holding
Funds holding: 157 [Q1] → 149 (-8) [Q2]
13.4% less ownership
Funds ownership: 54.06% [Q1] → 40.67% (-13.4%) [Q2]
22% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 49
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
40% less call options, than puts
Call options by funds: $758K | Put options by funds: $1.25M
42% less capital invested
Capital invested by funds: $135M [Q1] → $78.3M (-$57M) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3
467%
upside
Avg. target
$4.25
704%
upside
High target
$6
1,034%
upside
4 analyst ratings
3 positive
75%
1 neutral
25%
0 negative
0%
B of A Securities Jason Gerberry 38% 1-year accuracy 9 / 24 met price target | 467%upside $3 | Buy Maintained | 15 Aug 2024 |
RBC Capital Luca Issi 33% 1-year accuracy 16 / 48 met price target | 656%upside $4 | Sector Perform Reiterated | 15 Aug 2024 |
Barclays Gena Wang 42% 1-year accuracy 10 / 24 met price target | 656%upside $4 | Overweight Maintained | 15 Aug 2024 |
Baird Jack Allen 50% 1-year accuracy 4 / 8 met price target | 1,034%upside $6 | Outperform Maintained | 15 Aug 2024 |
Financial journalist opinion
Based on 6 articles about BLUE published over the past 30 days